These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2470994)

  • 21. Carvedilol inhibits endothelin-1 biosynthesis in cultured human coronary artery endothelial cells.
    Ohlstein EH; Arleth AJ; Storer B; Romanic AM
    J Mol Cell Cardiol; 1998 Jan; 30(1):167-73. PubMed ID: 9500873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different inhibition by vasodilators of coronary artery contraction.
    Inoue S; Kinoshita M; Toda N
    Arch Int Pharmacodyn Ther; 1988; 295():181-93. PubMed ID: 3245734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology of carvedilol.
    Dulin B; Abraham WT
    Am J Cardiol; 2004 May; 93(9A):3B-6B. PubMed ID: 15144929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasodilatory action of carvedilol.
    Sponer G; Strein K; Bartsch W; Müller-Beckmann B
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S5-11. PubMed ID: 1378150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carvedilol retards sudden loss of contraction during early regional myocardial ischemia in feline hearts.
    Brunvand H; Grong K
    J Pharmacol Exp Ther; 1997 Jul; 282(1):363-8. PubMed ID: 9223575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral administration of carvedilol and prazosin inhibits the prostaglandin F2 alpha- and noradrenaline-induced contraction of human hand veins in vivo.
    Beermann C; Schloos J; Belz GG
    Clin Investig; 1992; 70 Suppl 1():S13-9. PubMed ID: 1317234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanisms of the relaxation induced by vasoactive intestinal peptide in the porcine coronary artery.
    Kawasaki J; Kobayashi S; Miyagi Y; Nishimura J; Fujishima M; Kanaide H
    Br J Pharmacol; 1997 Jul; 121(5):977-85. PubMed ID: 9222556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the mode of vasodilating action of carvedilol.
    Sponer G; Strein K; Müller-Beckmann B; Bartsch W
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S42-8. PubMed ID: 2454366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E4080 has a dual action, as a K+ channel opener and a Ca2+ channel blocker, in canine coronary artery smooth muscle.
    Okada Y; Yanagisawa T; Taira N
    Eur J Pharmacol; 1992 Aug; 218(2-3):259-64. PubMed ID: 1330597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
    Asanuma H; Minamino T; Sanada S; Takashima S; Ogita H; Ogai A; Asakura M; Liao Y; Asano Y; Shintani Y; Kim J; Shinozaki Y; Mori H; Node K; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Jun; 109(22):2773-9. PubMed ID: 15148268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.
    Fujio H; Nakamura K; Matsubara H; Kusano KF; Miyaji K; Nagase S; Ikeda T; Ogawa A; Ohta-Ogo K; Miura D; Miura A; Miyazaki M; Date H; Ohe T
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):250-5. PubMed ID: 16495763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypotensive properties.
    Sponer G; Bartsch W; Strein K; Müller-Beckmann B; Böhm E
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):317-27. PubMed ID: 2437399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
    Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
    Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory action of carvedilol, a novel alpha, beta-adrenoceptor antagonist, on catecholamine secretion and calcium influx in cultured bovine adrenal chromaffin cells.
    Morita K; Hamano S; Yoshizumi M; Oka M
    Biochem Pharmacol; 1989 Dec; 38(24):4461-5. PubMed ID: 2574976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of carvedilol on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes.
    Deng C; Yu X; Kuang S; Zhang W; Zhou Z; Zhang K; Qian W; Shan Z; Yang M; Wu S; Lin S
    Life Sci; 2007 Jan; 80(7):665-71. PubMed ID: 17118405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relaxation by cromakalim and pinacidil of isolated smooth muscle cells from canine coronary artery-multiple sites of action.
    Rhim BY; Hong KW
    Arch Int Pharmacodyn Ther; 1994; 328(1):67-81. PubMed ID: 7893192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible alpha-adrenoceptor blocking activity of arotinolol (S-596), a new beta-adrenoceptor blocking agent in isolated dog coronary artery.
    Sakanashi M; Miyamoto Y; Ito H; Takeo S; Noguchi K; Higa T
    Pharmacology; 1984; 29(4):204-9. PubMed ID: 6208564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacology of carvedilol.
    Ruffolo RR; Gellai M; Hieble JP; Willette RN; Nichols AJ
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S82-8. PubMed ID: 1974511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressive Effect of Carvedilol on Na+/Ca2+ Exchange Current in Isolated Guinea-Pig Cardiac Ventricular Myocytes.
    Tashiro M; Watanabe Y; Yamakawa T; Yamashita K; Kita S; Iwamoto T; Kimura J
    Pharmacology; 2017; 99(1-2):40-47. PubMed ID: 27673688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamic profile of carvedilol.
    van Zwieten PA
    Cardiology; 1993; 82 Suppl 3():19-23. PubMed ID: 8106159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.